| Clinical Guidelines |
0 |
1 |
| Osteoarthritis |
0 |
0.87 |
| Clostridium Difficile Infection |
0 |
0.7 |
| Treatment Guidelines |
0 |
0.99 |
| Pain Management |
0 |
0.43 |
| Microbiome |
0 |
0.33 |
| Biologic Therapy |
0 |
0.26 |
| Antibiotics |
0 |
0.25 |
| Knee Osteoarthritis |
0 |
0.23 |
| Toxicology |
0 |
0.18 |
| Opioids |
0 |
0.17 |
| Pain |
0 |
0.14 |
| Sexually Transmitted Infection |
0 |
0.14 |
| Washington |
0 |
0.14 |
| Abdominal Pain |
0 |
0.13 |
| Fecal Transplant |
0 |
0.1 |
| Exercise |
0 |
0.09 |
| Narcotic |
0 |
0.09 |
| Transplantation |
0 |
0.09 |
| Acromegaly |
0 |
0.08 |
| Arthroplasty |
0 |
0.08 |
| Diarrhea |
0 |
0.08 |
| Herpes Simplex |
0 |
0.08 |
| Pregnancy |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |
| Society for Healthcare Epidemiology of America |
0 |
0.07 |
| Abdomen |
0 |
0.05 |
| Antiviral Agents |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Centers for Disease Control and Prevention |
0 |
0.05 |
| Chlamydial Infection |
0 |
0.05 |
| Clerkship |
0 |
0.05 |
| Clostridial Infection |
0 |
0.05 |
| Epidemiology |
0 |
0.05 |
| Fever |
0 |
0.05 |
| Gonorrhea |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.05 |
| Quality of Life |
0 |
0.05 |
| Students |
0 |
0.05 |